SLC2A4 and neoplasm: Ecdysoneless (ECD) has been studied as a tumor-promoting gene in PDAC that activates pAkt, a molecule that regulates glycolysis in tumor cells and enhances the expression of solute carrier family 2 (facilitated glucose transporter), member 4 (GLUT4) to strengthen glycolysis [68].